Trial Profile
Prediction of delayed response in naive chronic hepatitis B patients to 48 weeks of entecavir treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 19 Dec 2015 New trial record